We have shown that GSK-3 inhibitors activate JNK in gastric adenocarcinoma cells, which regulate negatively on TRAIL-induced apoptosis, thereby providing a anti-apoptotic signal. Here, MAPK8 is linked to gastric adenocarcinoma.